BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 27519355)

  • 1. Five-year mortality outcomes in patients with chronic kidney disease undergoing percutaneous coronary intervention.
    Patel AD; Ibrahim M; Swaminathan RV; Minhas IU; Kim LK; Venkatesh P; Feldman DN; Minutello RM; Bergman GW; Wong SC; Singh HS
    Catheter Cardiovasc Interv; 2017 Mar; 89(4):E124-E132. PubMed ID: 27519355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention.
    Parikh PB; Jeremias A; Naidu SS; Brener SJ; Lima F; Shlofmitz RA; Pappas T; Marzo KP; Gruberg L
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):352-7. PubMed ID: 22566286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of Mild-to-Moderate Chronic Kidney Disease on One Year Outcomes after Percutaneous Coronary Intervention.
    Grandjean-Thomsen NL; Marley P; Shadbolt B; Farshid A
    Nephron; 2017; 137(1):23-28. PubMed ID: 28478459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes after percutaneous coronary intervention for chronic total occlusion according to baseline renal function.
    Stähli BE; Gebhard C; Gick M; Ferenc M; Mashayekhi K; Buettner HJ; Neumann FJ; Toma A
    Clin Res Cardiol; 2018 Mar; 107(3):259-267. PubMed ID: 29134346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Off-pump bilateral skeletonized internal thoracic artery grafting in patients with chronic kidney disease.
    Kinoshita T; Asai T; Suzuki T
    J Thorac Cardiovasc Surg; 2015 Aug; 150(2):315-21.e3. PubMed ID: 26142149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcomes of patients with stable coronary disease and chronic kidney dysfunction: 10-year follow-up of the Medicine, Angioplasty, or Surgery Study II Trial.
    Lima EG; Charytan DM; Hueb W; de Azevedo DFC; Garzillo CL; Favarato D; Linhares Filho JPP; Martins EB; Batista DV; Rezende PC; Hueb AC; Ramires JAF; Kalil Filho R
    Nephrol Dial Transplant; 2020 Aug; 35(8):1369-1376. PubMed ID: 30590726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased cystatin C levels as a risk factor of cardiovascular events in patients with preserved estimated glomerular filtration rate after elective percutaneous coronary intervention with drug-eluting stents.
    Sai E; Shimada K; Miyauchi K; Masaki Y; Kojima T; Miyazaki T; Kurata T; Ogita M; Tsuboi S; Yoshihara T; Miyazaki T; Ohsaka A; Daida H
    Heart Vessels; 2016 May; 31(5):694-701. PubMed ID: 25863806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic kidney disease and diabetes associated with long-term outcomes in patients receiving percutaneous coronary intervention.
    Lin MJ; Lee J; Chen CY; Huang CC; Wu HP
    BMC Cardiovasc Disord; 2017 Sep; 17(1):242. PubMed ID: 28893175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of STEMI patients with chronic kidney disease treated with percutaneous coronary intervention: the Malaysian National Cardiovascular Disease Database - Percutaneous Coronary Intervention (NCVD-PCI) registry data from 2007 to 2014.
    Ismail MD; Jalalonmuhali M; Azhari Z; Mariapun J; Lee ZV; Zainal Abidin I; Wan Ahmad WA; Zuhdi ASM;
    BMC Cardiovasc Disord; 2018 Sep; 18(1):184. PubMed ID: 30249197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rates of future hemodialysis risk and beneficial outcomes for patients with chronic kidney disease undergoing recanalization of chronic total occlusion.
    Shimura T; Yamamoto M; Tsuchikane E; Teramoto T; Kimura M; Matsuo H; Kawase Y; Suzuki Y; Kano S; Habara M; Nasu K; Kinoshita Y; Terashima M; Matsubara T; Suzuki T
    Int J Cardiol; 2016 Nov; 222():707-713. PubMed ID: 27521544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative effectiveness of coronary artery bypass grafting and percutaneous coronary intervention for multivessel coronary disease in a community-based population with chronic kidney disease.
    Chang TI; Leong TK; Kazi DS; Lee HS; Hlatky MA; Go AS
    Am Heart J; 2013 May; 165(5):800-8, 808.e1-2. PubMed ID: 23622918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Choice of Estimated Glomerular Filtration Rate Equation Impacts Drug-Dosing Recommendations and Risk Stratification in Patients With Chronic Kidney Disease Undergoing Percutaneous Coronary Interventions.
    Parsh J; Seth M; Aronow H; Dixon S; Heung M; Mehran R; Gurm HS
    J Am Coll Cardiol; 2015 Jun; 65(25):2714-23. PubMed ID: 26112195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term patient and kidney survival after coronary artery bypass grafting, percutaneous coronary intervention, or medical therapy for patients with chronic kidney disease: a propensity-matched cohort study.
    Vuurmans T; Er L; Sirker A; Djurdjev O; Simkus G; Levin A
    Coron Artery Dis; 2018 Jan; 29(1):8-16. PubMed ID: 28938241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Short- and long-term outcomes of coronary artery bypass grafting or drug-eluting stent implantation for multivessel coronary artery disease in patients with chronic kidney disease.
    Ashrith G; Lee VV; Elayda MA; Reul RM; Wilson JM
    Am J Cardiol; 2010 Aug; 106(3):348-53. PubMed ID: 20643244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ORBIT II sub-analysis: Impact of impaired renal function following treatment of severely calcified coronary lesions with the Orbital Atherectomy System.
    Lee MS; Lee AC; Shlofmitz RA; Martinsen BJ; Hargus NJ; Elder MD; Généreux P; Chambers JW
    Catheter Cardiovasc Interv; 2017 Apr; 89(5):841-848. PubMed ID: 27567020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Chronic Kidney Disease on Cardiovascular and Renal Events in Patients Undergoing Percutaneous Coronary Intervention with Everolimus-Eluting Stent: Risk Stratification with C-Reactive Protein.
    Dan K; Miyoshi T; Nakahama M; Mizuno T; Kagawa K; Naito Y; Kawada S; Ito H
    Cardiorenal Med; 2018; 8(2):151-159. PubMed ID: 29617004
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with end-stage renal disease requiring dialysis (5-year outcomes of the CREDO-Kyoto PCI/CABG Registry Cohort-2).
    Marui A; Kimura T; Nishiwaki N; Mitsudo K; Komiya T; Hanyu M; Shiomi H; Tanaka S; Sakata R;
    Am J Cardiol; 2014 Aug; 114(4):555-61. PubMed ID: 24996550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In-Hospital Outcomes of Chronic Total Occlusion Percutaneous Coronary Intervention in Patients With Chronic Kidney Disease.
    Tajti P; Karatasakis A; Danek BA; Alaswad K; Karmpaliotis D; Jaffer FA; Choi JW; Yeh RW; Patel M; Mahmud E; Burke MN; Krestyaninov O; Khelimskii D; Toma C; Doing AH; Uretsky B; Koutouzis M; Tsiafoutis I; Wyman RM; Garcia S; Holper E; Xenogiannis I; Rangan BV; Banerjee S; Ungi I; Brilakis ES
    J Invasive Cardiol; 2018 Nov; 30(11):E113-E121. PubMed ID: 30218557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of chronic kidney disease on long-term outcomes following semi-urgent and elective percutaneous coronary intervention.
    Soh RY; Sia CH; Lau RH; Ho PY; Timothy NY; Ho JS; Kaur H; Sim HW; Yeo TC; Tan HC; Chan MY; Loh JP
    Coron Artery Dis; 2021 Sep; 32(6):517-525. PubMed ID: 33229937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of Chronic Kidney Disease in Women Undergoing Percutaneous Coronary Intervention With Drug-Eluting Stents: A Patient-Level Pooled Analysis of Randomized Controlled Trials.
    Baber U; Giustino G; Sartori S; Aquino M; Stefanini GG; Steg PG; Windecker S; Leon MB; Wijns W; Serruys PW; Valgimigli M; Stone GW; Dangas GD; Morice MC; Camenzind E; Weisz G; Smits PC; Kandzari D; Von Birgelen C; Mastoris I; Galatius S; Jeger RV; Kimura T; Mikhail GW; Itchhaporia D; Mehta L; Ortega R; Kim HS; Kastrati A; Chieffo A; Mehran R
    JACC Cardiovasc Interv; 2016 Jan; 9(1):28-38. PubMed ID: 26762908
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.